Search
for
Sort by
Research 661–690 of 1000+
- Cosmeceutical Applications of Phlorotannins from Brown Seaweeds
- Therapeutic effects of topical Mycophenolate mofetil on hydroquinone-induced depigmentation in Guinea pigs and mice
- Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2
- Receptor tyrosine kinase Kit action in skin melanocytes: is it exclusively cell autonomous?
- Characterisation, genomic organisation, expression and function of the mEphA1 receptor Tyrosine Kinase
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Acneiform eruptions caused by an epidermal growth factor receptor-tyrosine kinase inhibitor ZD 1839
- Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors
- 2,3,7,8‐Tetrachlorodibenzo‐<i>p</i>‐dioxin causes an increase in protein kinases growth hepatic associated with epidermal factor receptor in the plasma membrane
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
- Erlotinib-induced trichomegaly of eyelashes in lung cancer treatment: Epidermal growth factor receptor inhibitor side effect
- Epidermal growth factor receptor mutant T790M-L858R-V948R inhibitor from Calophyllum inophyllum L. leaf as potential non-small cell lung cancer drugs
- Signaling by the Platelet-Derived Growth Factor Receptor Family
- MicroRNA control of signal transduction
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- Botryococcus terribilis Ethanol Extract Exerts Anti-inflammatory Effects on Murine RAW264 Cells
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Periocular Manifestations of Afatinib Therapy
- Hair Growth After Gefitinib Treatment
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Severe scarring alopecia associated with combinational use of ficlatuzumab and gefitinib: a clinical and immunohistochemistry study
- Axitinib-induced repigmentation of grey hair in a patient with metastatic renal cell carcinoma
- Erlotinib-Associated Alopecia in a Lung Cancer Patient
- Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
- Hair graying and loss induced by imatinib mesylate
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy